Search

Background and Objectives: Restless legs syndrome (RLS) has been associated with anxiety, depression, insomnia, lifestyle factors and infections. We aimed to study the prevalence of symptoms of RLS during the COVID-19 pandemic versus pre-pandemic. We hypothesized that pre-existing RLS symptoms worsened and pandemic-related factors may have triggered new symptoms of RLS., Methods: Adults (≥18 years) from fifteen countries across four continents participated in an online survey between May and August 2020. The harmonized questionnaire included a validated single question on RLS with response alternatives from 1 to 5 on a scale from never to every/almost every evening or night. Other measures were the Insomnia Severity Index (ISI), measures of symptoms of anxiety (GAD-2) and depression (PHQ-2), and questions on different pandemic-related factors., Results: Altogether, 17 846 subjects (63.8 % women) were included in the final analyses. The mean age was 41.4 years (SD 16.1). During the pandemic, symptoms of RLS (≥3 evenings/nights per week) were more common 9.1 % (95 % CI 8.7-10.1) compared to 5.4 % (95 % CI 4.9-6.0) before the pandemic (P < 0.0001). Alltogether 1.3 % (95 % CI 1.1-1.6) respondents had new-onset symptoms (≥3 evenings/nights per week). Moderate-severe insomnia was strongly associated with RLS symptoms. The occurrences of new-onset RLS symptoms were 5.6 % (95 % CI 0.9-13.0) for participants reporting COVID-19 and 1.1 % (95 % CI 0.7-1.5) for non-COVID-19 participants. In the fully adjusted logistic regression model, the occurrence of new-onset RLS symptoms was associated with younger age, social restrictions and insomnia severity. In a similar analysis, RLS symptoms (≥3 evenings/nights per week) were associated with lower education, financial hardship, sleep apnea symptoms, use of hypnotics, insomnia severity, symptoms of depression and possible post-traumatic stress disorder., Discussion: Our findings indicate that RLS symptoms were more common during the pandemic than before. Usually, the prevalence of RLS increases with age. However, during the pandemic, new-onset symptoms of RLS were more common in younger age groups. This may be due to the pandemic-related factors being more pronounced in the younger compared to the older. The association between insomnia, psychiatric symptoms and RLS warrants clinical attention., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Markku Partinen reports financial support was provided by Signe and Ane Gyllenberg Foundation. Other from Takeda, personal fees and other from MSD, personal fees and other from Orion, personal fees and other from Umecrine, personal fees from Lundbeck, Other from Teva, outside the submitted work. Ilona Merikanto reports financial support was provided by Signe and Ane Gyllenberg Foundation. Courtney J. Bolstad reports financial support was provided by South Texas Veterans Healthcare System. Yuichi Inoue reports personal fees and other from Astellas Pharma, personal fees from Eisai, other from Idorsia Pharmaceuticals Japan, grants from Koike Medical, personal fees from Otsuka Pharmaceutical, grants from Philips Japan, outside the submitted work. Frances Chung – Dr. Chung reports grants from Ontario Ministry of Health Innovation Grant, grants from University Health NetworkFoundation, personal fees from Masimo Inc and Takeda Pharma, outside the submitted work; In addition, University Health Network has a patent STOP-Bang questionnaire pending. Thomas Penzel – Dr. Penzel reports personal fees from Jazz Pharmaceuticals, personal fees from Bayer Healthcare, personal fees from Neuwirth, personal fees from Löwenstein Medical, outside the submitted work; and Shareholder of The Siestagroup GmbH, Advanced Sleep Research GmbH, Nukute. Giuseppe Plazzi – Dr. Plazzi reports personal fees from UCB pharma, personal fees from Jazz pharmaceuticals, personal fees from Bioprojet, personal fees from Idorsia, personal fees from Takeda, outside the submitted work. YK Wing – personal fees from Eisai Co, Ltd, for delivering a lecture and sponsorship from Lundbeck HK Ltd and Aculys Pharma, Japan, outside the submitted work. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier B.V.)

Objective: There is evidence of a strong association between insomnia and COVID-19, yet few studies have examined the relationship between insomnia and long COVID. This study aimed to investigate whether COVID-19 patients with pre-pandemic insomnia have a greater risk of developing long COVID and whether long COVID is in turn associated with higher incident rates of insomnia symptoms after infection., Methods: Data were collected cross-sectionally (May-Dec 2021) as part of an international collaborative study involving participants from 16 countries. A total of 2311 participants (18-99 years old) with COVID-19 provided valid responses to a web-based survey about sleep, insomnia, and health-related variables. Log-binomial regression was used to assess bidirectional associations between insomnia and long COVID. Analyses were adjusted for age, sex, and health conditions, including sleep apnea, attention and memory problems, chronic fatigue, depression, and anxiety., Results: COVID-19 patients with pre-pandemic insomnia showed a higher risk of developing long COVID than those without pre-pandemic insomnia (70.8% vs 51.4%; adjusted relative risk [RR]: 1.33, 95% confidence interval [CI]: 1.07-1.65). Among COVID-19 cases without pre-pandemic insomnia, the rates of incident insomnia symptoms after infection were 24.1% for short COVID cases and 60.6% for long COVID cases (p < .001). Compared with short COVID cases, long COVID cases were associated with an increased risk of developing insomnia symptoms (adjusted RR: 2.00; 95% CI: 1.50-2.66)., Conclusions: The findings support a bidirectional relationship between insomnia and long COVID. These findings highlight the importance of addressing sleep and insomnia in the prevention and management of long COVID., Competing Interests: Declaration of competing interest Authors declare none., (Crown Copyright © 2023. Published by Elsevier B.V. All rights reserved.)

Background: The COVID-19 pandemic and related restriction measures have affected our daily life, sleep, and circadian rhythms worldwide. Their effects on hypersomnolence and fatigue remain unclear., Methods: The International COVID-19 Sleep Study questionnaire which included items on hypersomnolence such as excessive daytime sleepiness (EDS), and excessive quantity of sleep (EQS), as well as sociodemographic factors, sleep patterns, psychological symptoms, and quality of life was distributed in 15 countries across the world from May to September in 2020., Results: Altogether responses from 18,785 survey participants (65% women, median age 39 years) were available for analysis. Only 2.8% reported having had COVID-19. Compared to before the pandemic, the prevalence of EDS, EQS, and fatigue increased from 17.9% to 25.5%, 1.6%-4.9%, and 19.4%-28.3% amid the pandemic, respectively. In univariate logistic regression models, reports of having a COVID-19 were associated with EQS (OR 5.3; 95%-CI 3.6-8.0), EDS (2.6; 2.0-3.4), and fatigue (2.8; 2.1-3.6). In adjusted multivariate logistic regression, sleep duration shorter than desired (3.9; 3.2-4.7), depressive symptoms (3.1; 2.7-3.5), use of hypnotics (2.3; 1.9-2.8), and having reported COVID-19 (1.9; 1.3-2.6) remained strong predictors of EDS. Similar associations emerged for fatigue. In the multivariate model, depressive symptoms (4.1; 3.6-4.6) and reports of having COVID-19 (2.0; 1.4-2.8) remained associated with EQS., Conclusions: A large increase in EDS, EQS, and fatigue occurred due to the COVID-19 pandemic, and especially in self-reported cases of COVID-19. These findings warrant a thorough understanding of their pathophysiology to target prevention and treatment strategies for long COVID condition., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.)

Importance and Study Objective: The COVID-19 pandemic has produced unprecedented changes in social, work, and leisure activities, which all have had major impact on sleep and psychological well-being. This study documented the prevalence of clinical cases of insomnia, anxiety, and depression and selected risk factors (COVID-19, confinement, financial burden, social isolation) during the first wave of the pandemic in 13 countries throughout the world., Design and Participants: International, multi-center, harmonized survey of 22 330 adults (mean age = 41.9 years old, range 18-95; 65.6% women) from the general population in 13 countries and four continents. Participants were invited to complete a standardized web-based survey about sleep and psychological symptoms during the first wave of the COVID-19 pandemic from May to August 2020., Results: Clinical insomnia symptoms were reported by 36.7% (95% CI, 36.0-37.4) of respondents and 17.4% (95% CI, 16.9-17.9) met criteria for a probable insomnia disorder. There were 25.6% (95% CI, 25.0-26.2) with probable anxiety and 23.1% (95% CI, 22.5-23.6) with probable depression. Rates of insomnia symptoms (>40%) and insomnia disorder (>25%) were significantly higher in women, younger age groups, and in residents of Brazil, Canada, Norway, Poland, USA, and United Kingdom compared to residents from Asian countries (China and Japan, 8% for disorder and 22%-25% for symptoms) (all Ps < 0.01). Proportions of insomnia cases were significantly higher among participants who completed the survey earlier in the first wave of the pandemic relative to those who completed it later. Risks of insomnia were higher among participants who reported having had COVID-19, who reported greater financial burden, were in confinement for a period of four to five weeks, and living alone or with more than five people in same household. These associations remained significant after controlling for age, sex, and psychological symptoms., Conclusion and Relevance: Insomnia, anxiety, and depression were very prevalent during the first wave of the COVID-19 pandemic. Public health prevention programs are needed to prevent chronicity and reduce long-term adverse outcomes associated with chronic insomnia and mental health problems., (Copyright © 2021 Elsevier B.V. All rights reserved.)

Objective: Associations of eveningness with health hazards benefit from analyzing to what extent the polygenic score for morningness correlates with the assessments of the behavioral trait of morningness-eveningness and chronotype., Methods: With a population-based sample of 17,243 Finnish adults, aged 25-74 years, this study examines the associations of four feasible assessment methods of chronotype, a) biological the genetic liability based on the polygenic score for morningness (PGS morn ), b) the widely-used single item for self-assessed morningness/eveningness (MEQ i19 ) of the original Morningness-Eveningness Questionnaire (MEQ), c) the behavioral trait of morningness-eveningness as assessed with the score on the shortened version (sMEQ) of the original MEQ, and d) the phase of entrainment as assessed with the habitual midpoint of sleep based on the self-reported sleep-wake schedule during weekend (Sleep mid-wknd ) as well as the sleep debt corrected midpoint of sleep (Sleep mid-corr )., Results: All self-report measures correlated with each other, but very weakly with the PGS morn , which explained 1-2% of the variation in diurnal preference or habitual sleep-wake schedule. The influence of age was greater on Sleep mid-wknd and Sleep mid-corr than on the sMEQ or MEQ i19 , indicating that the diurnal preference might be a more stable indicator for morningness-eveningness than the sleep-wake schedule. Analyses of the discrepancies between sMEQ and MEQ i19 indicated that eveningness can be over-estimated when relying on only the single-item self-assessment., Conclusions: The current polygenic score for morningness explains only a small proportion of the variation in diurnal preference or habitual sleep-wake schedule. The molecular genetic basis for morningness-eveningness needs further elucidation., (Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.)

Objectives: Short or long sleep duration, insufficient sleep, and Evening chronotype associate with many health issues and increased risk for mortality. Understanding population-level changes in sleep and chronotype frequencies is important for assessing the prospective health status of the society and future challenges on health care at a national level. This study examines the cross-sectional differences in sleep duration, insufficient sleep, and chronotype frequencies indicated by both circadian preference and habitual sleep-wake rhythm among adults living in Finland during a 10-year period of 2007-2017., Methods: The study sample (N = 18 039) was derived from he National FINRISK 2007 and 2012 Studies, and The FinHealth 2017 Study, each consisting of a random sample of adults, aged 25-74 years and as stratified by age and sex, and providing the self-reported data on their circadian preference, habitual daily sleep duration, insufficient sleep and bedtimes., T Results: During the 10 years, sleep duration decreased, insufficient sleep increased and circadian preference towards eveningness increased significantly in each 10-year age group and among both sexes. In general, eveningness was more common among younger adults in all the study years but, as compared to 2012, in 2017 bedtimes and midpoint of sleep were more advanced among this age group while sleep-wake rhythm became more delayed in older adults. The decrease in sleep duration and the increase in insufficient sleep were emphasized in younger adults and especially in women, whereas the increase in eveningness in older adults and in men., Conclusions: The evolution of sleep and chronotype frequencies from 2007 to 2017 is alarming, as these might lead to a poorer health status in the adult population and thus cause more strain to the public health. The mismatch between sleep-wake behavior and circadian preference was emphasized in young adults, indicating a greater risk for circadian misalignment in the Finnish adult population in the future, if there will not be any interventions to correct this mismatch., (Copyright © 2020 Elsevier B.V. All rights reserved.)

Objective: Adolescence is often associated with decline in physical activity (PA) and a circadian shift towards eveningness, but it is not known whether these transitions are intertwined. We explored longitudinally and in cross-section how chronotype and genetic liability for morningness associate with PA as self-reported and measured by actigraphy in early and late adolescence., Methods: Our sample comes from a longitudinal Finnish community-cohort born in 1998 with information on actigraph-based PA and objectively measured sleep-wake rhythm based on midpoint of sleep at ages 12 (N = 353, girls = 187) and 17 (N = 171, girls = 98). Information on self-reported circadian preference and subjective PA was available at age 17. The summarized genetic effects of multiple single nucleotide polymorphism for morningness was assessed by calculating polygenic score (PGS) based on the results on a recent genome-wide association study (GWAS)., Results: PA declined by 40% (p < 0.0001) in boys and by 32% in girls (p < 0.0001) from age 12 to 17. Later midpoint of sleep correlated significantly with lower level of general, light and moderate to vigorous PA only at age 12 (all p < 0.05) but not at age 17 (all p ≥ 0.36). However, those with circadian preference more towards eveningness at age 17 had more sedentary behavior (p < 0.01) and a lower level of general (p = 0.01), light (p < 0.01) and moderate to vigorous PA (p < 0.05). They also had poorer subjective assessment of their fitness level (p < 0.01) and they exercised less (all p ≤ 0.05). The decline in objectively measured PA and increase in sedentary behavior from age 12 to 17 was emphasized among those with circadian preference towards eveningness (p < 0.05). PGS for morningness was not significantly associated with PA in adolescence (all p ≥ 0.13)., Conclusions: Findings of this study highlighted the influence of circadian preference on physical activity behavior in adolescence. Self-assessed circadian preference towards eveningness associated with lower PA and greater decline of it during adolescence. Furthermore, PA declined significantly especially among boys from early to late adolescence. Interventions encouraging physical activity should target specifically evening-oriented adolescents., (Copyright © 2020 Elsevier B.V. All rights reserved.)

Objective: Diagnosed autism spectrum disorders have been associated with a high prevalence of sleep problems, other psychiatric disorders and social deficits in adolescence. However, little is known about the possible connection between subclinical autistic traits and sleep. This study explored whether adolescents with elevated levels of subclinical autistic traits are at heightened risk for sleep problems., Methods: This study used data from the community cohort born in 1998. The sample consisted of 157 (57% girls) 17-year-old adolescents. Autistic traits were assessed using the Autism Spectrum Quotient (AQ). The Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and the Adult ADHD Self-Report Scale were utilized to control for comorbid psychiatric symptoms. Sleep was measured with actigraphy and sleep quality was self-rated using the Pittsburgh Sleep Quality Index (PSQI). Associations between autistic traits and sleep were examined using logistic regression analysis., Results: Elevated levels of autistic traits were significantly associated with shorter weekday sleep duration. Moreover, autistic traits remained an independent predictor of short sleep duration when comorbid psychiatric symptoms were controlled for (OR 1.14; 95% CI: 1.03-1.26)., Conclusions: The results suggest that subclinical autistic traits should be considered as a possible underlying mechanism affecting adolescent sleep., (Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.)

Objective: Recent genome-wide association studies (GWASs) have revealed new genetic variants behind self-reported individual circadian preference, a distinct biological trait that is fairly stable during adulthood. In this study we analyze whether these genetic variants associate with objectively measured sleep timing from childhood to adolescence, over a nine-year period, with self-reported circadian preference during late adolescence., Methods: The participants (N = 100, 61% girls) came from a community cohort from Finland born in 1998. Sleep midpoint was measured with actigraphy at 8, 12 and 17 years. Circadian preference was self-reported at the age of 17 years. Single nucleotide polymorphisms (SNPs) were extracted at 12 years of age from the Illumina OmniExpress Exome 1.2 bead array data. Weighted polygenic risk scores (PRSs) were calculated based on top SNPs from a recent GWAS for morningness-eveningness in an adult population., Results: The PRS for circadian preference towards morningness was associated with earlier sleep midpoint from childhood to adolescence. When the time points were analyzed separately, the association between genetic tendency towards morning preference and earlier sleep midpoint was strongest among the 17-year-olds. Furthermore, the shift towards later sleep rhythm from early to late adolescence was milder for those with a higher PRS for morning preference. PRS for morning preference was also associated with self-reported circadian preference towards morningness in late adolescence., Conclusion: Our results suggest that genetic variants found for circadian preference in adults are already associated with objective sleep timing during childhood and adolescence, and predict individual developmental sleep trajectories from childhood onwards., (Copyright © 2018. Published by Elsevier B.V.)

Study Objectives: Our study explored if bedtimes influenced school performance and motivation, as well as the odds ratio (OR) for health-related concerns in adolescents., Methods: The School Health Promotion Study was based on an anonymous self-report questionnaire conducted in 90% of the municipalities in Finland. The study was conducted during 2008 and 2010 in Southern Finland, Eastern Finland, and Lapland, and during 2009 and 2011 in Western Finland, Northern Finland, and Åland. Several indicators were used to measure school performance and motivation. Accidents and health-related complaints, such as depressive symptoms, sleep quality, neck or shoulder pains, lower back pains, stomachaches, anxiety or nervousness, irritation or tantrums, headaches, and tiredness or dizziness were analyzed in relation to the usual bedtime. Our study had a relatively large sample size (N=384,076), consisting of students in the eighth and the ninth grades of secondary schools and the first and the second grades of upper secondary and vocational schools (ages 14-20 years) in Finland., Results: All of the various indicators used to assess school performance and motivation suggest that the later the bedtime of adolescents, the lower their school performance and their motivation. Similarly later bedtimes increase the OR for depressive symptoms and other negative health consequences in adolescents as well as a tendency towards accidents. All of these problems were emphasized in students with bedtimes of 11:30 PM and later., Conclusions: Late bedtimes, especially those after 11:30 PM, indicate poor sleep which deteriorates school performance and motivation and increases the OR for depressive symptoms and other health-related issues in adolescents., (Copyright © 2013 Elsevier B.V. All rights reserved.)